• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results

    12/12/23 11:58:48 AM ET
    $ACHV
    $ADTX
    $CCCC
    $GGE
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACHV alert in real time by email

    U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday.

    The Dow traded up 0.35% to 36,533.63 while the NASDAQ rose 0.16% to 14,455.15 The S&P 500 also rose, gaining, 0.10% to 4,627.04

    Check This Out: Microsoft, U.S. Bancorp And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Industrials shares rose by 0.3% on Tuesday.

    In trading on Tuesday, energy shares fell by 1%.

     

    Top Headline

     

    Oracle Corporation (NYSE:ORCL) reported upbeat earnings for its second quarter, while sales missed estimates.

    Oracle reported quarterly adjusted earnings of $1.34 per share, topping the Street's estimate of $1.32. Revenue of $12.94 billion fell short of the analyst consensus estimate of $13.05 billion.

     

    Equities Trading UP

     

    Aditxt, Inc. (NASDAQ:ADTX) shares shot up 78% to $6.76. Aditxt agreed to acquire Evofem Biosciences in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain senior indebtedness, having an aggregate amount of approximately $100 million.

    Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC) got a boost, surging 93% to $2.28. C4 Therapeutics entered into an exclusive license and collaboration agreement with Merck & Co to develop degrader-antibody conjugates (DACs), an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells.

    Icosavax, Inc. (NASDAQ:ICVX) shares were also up, gaining 48% to $15.51. AstraZeneca agreed to acquire Icosavax at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.

     

    Equities Trading DOWN

     

    Achieve Life Sciences, Inc. (NASDAQ:ACHV) shares dropped 40% to $3.2697. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline. Oppenheimer maintained Achieve Life Sciences with an Outperform and lowered the price target from $21 to $18.

    Shares of Harbor Custom Development, Inc. (NASDAQ:HCDI) were down 26% to $0.5015. Harbor Custom Development voluntarily filed for protection under Chapter 11 Bankruptcy.

    Green Giant Inc. (NASDAQ:GGE) was down, falling 40% to $0.0913 as the company announced pricing of public offering.

    Also Check This Out: Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

     

    Commodities

     

    In commodity news, oil traded down 2.5% to $69.52 while gold traded up 0.2% at $1,998.50.

    Silver traded up 0.3% to $23.13 on Tuesday while copper rose 0.1% to $3.7850.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 fell 0.21%, London’s FTSE 100 rose 0.02% while Spain’s IBEX 35 Index fell 0.63% The German DAX rose 0.01% French CAC 40 rose 0.06%, while Italy’s FTSE MIB Index fell 0.07%.

    The ZEW Indicator of Economic Sentiment for the Eurozone surged by 9.2 points to 23 in December, recording the strongest reading in ten months, while German ZEW Indicator of Economic Sentiment rose to 12.8 in December from 9.8 in November.

    The number of job vacancies in the UK fell to 949,000 from September to November, while regular pay, excluding bonus payment in the UK, rose 7.3% year-over-year to GBP 620/week in the three months to October.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 0.16%, Hong Kong’s Hang Seng Index gaining 1.07% and China’s Shanghai Composite Index gaining 0.40%. India’s S&P BSE Sensex, meanwhile, fell 0.54%.

    Producer prices in Japan increased 0.3% year-over-year in November following a revised 0.9% rise in October.

     

    Economics

     

    The NFIB Small Business Optimism Index declined for a fourth straight month to a reading of 90.6 in November.

    The annual inflation rate in the U.S. eased to 3.1% in November, recording the lowest reading in five months, compared to 3.2% in October.

    Now Read This: Top 5 Utilities Stocks That Should Keep You Up At Night

    Get the next $ACHV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHV
    $ADTX
    $CCCC
    $GGE

    CompanyDatePrice TargetRatingAnalyst
    Oracle Corporation
    $ORCL
    4/24/2026$225.00Outperform
    Wedbush
    Achieve Life Sciences Inc.
    $ACHV
    4/21/2026$13.00Buy
    Canaccord Genuity
    Oracle Corporation
    $ORCL
    4/10/2026Buy → Neutral
    Cleveland Research
    Oracle Corporation
    $ORCL
    3/24/2026$200.00Buy
    BofA Securities
    Oracle Corporation
    $ORCL
    3/11/2026$210.00Neutral → Overweight
    Analyst
    Oracle Corporation
    $ORCL
    3/11/2026$205.00 → $200.00Outperform
    BMO Capital Markets
    Oracle Corporation
    $ORCL
    3/11/2026$185.00 → $210.00Outperform
    Oppenheimer
    Oracle Corporation
    $ORCL
    2/25/2026$185.00Perform → Outperform
    Oppenheimer
    More analyst ratings

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Tpg Gp A, Llc claimed ownership of 6,877,580 shares (SEC Form 3)

    3 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    4/24/26 5:03:09 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    New insider Iancovici Lucian claimed no ownership of stock in the company (SEC Form 3)

    3 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    4/24/26 5:01:21 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)

    4 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:43:04 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Related Digital Announces Financing for $16 Billion Oracle Data Center Project in Saline Township, Michigan

    Related Digital and Funds Affiliated with Blackstone Commit Equity to Fund Project; Fixed Rate, Long-Term Debt Financing Anchored by PIMCO-Managed Funds and AccountsCampus Creates Thousands of Union Construction Jobs and Significant Community Investment DALLAS, April 24, 2026 /PRNewswire/ -- Related Digital, a vertically integrated data center development and investment platform, and Blackstone (NYSE:BX) announced today that financing has been secured for Related Digital's $16 billion data center campus in Saline Township, Michigan, purpose-built for Oracle. The financing includes equity from Related Digital and funds affiliated with Blackstone, and fixed-rate, long term debt financing ancho

    4/24/26 7:17:00 PM ET
    $BAC
    $BX
    $ORCL
    Major Banks
    Finance
    Investment Managers
    Computer Software: Prepackaged Software

    Oracle Expands Powerful AI Capabilities in Oracle AI Database@Google Cloud to Supercharge Enterprise Data Innovation

    Secure, natural language access to Oracle data through Gemini Enterprise speeds insights without writing SQL AUSTIN, Texas, April 22, 2026 /PRNewswire/ -- Oracle has expanded its partnership with Google Cloud to give joint customers new ways to operationalize AI across enterprise data. Under the expanded partnership, the Oracle AI Database Agent for Gemini Enterprise gives Oracle AI Database@Google Cloud customers a simpler way to interact with their Oracle data using natural language. In addition, Oracle AI Database@Google Cloud now offers new capabilities and broader regional availability as global organizations, such as Worldline, use it to drive innovation and accelerate cloud migrations

    4/22/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Health Demonstrates Interoperability Leadership, Achieves CMS Aligned Network Status

    Delivers solution to eliminate check-in paperwork by leveraging CLEAR1 in support of CMS' "Kill the Clipboard" initiativeAUSTIN, Texas, April 20, 2026 /PRNewswire/ -- Advancing its mission to provide patients with access to their healthcare data when and where they need it, Oracle Health is now a Centers for Medicare & Medicaid Services (CMS) Aligned Network. Oracle Health has also developed and delivered an easy-to-implement solution that allows patients to digitally verify their identity and provide access to their health records at check-in. This eliminates redundant information gathering and reflects Oracle Health's commitment to reducing the administrative burden across the healthcare e

    4/20/26 9:13:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    SEC Filings

    View All

    SEC Form 11-K filed by Oracle Corporation

    11-K - ORACLE CORP (0001341439) (Filer)

    4/24/26 4:10:13 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B3 filed by Aditxt Inc.

    424B3 - Aditxt, Inc. (0001726711) (Filer)

    4/23/26 4:30:42 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by C4 Therapeutics Inc.

    SCHEDULE 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    4/22/26 5:27:16 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)

    4 - Aditxt, Inc. (0001726711) (Issuer)

    4/23/26 3:43:04 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wedbush initiated coverage on Oracle with a new price target

    Wedbush initiated coverage of Oracle with a rating of Outperform and set a new price target of $225.00

    4/24/26 8:06:10 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Canaccord Genuity initiated coverage on Achieve Life Sciences with a new price target

    Canaccord Genuity initiated coverage of Achieve Life Sciences with a rating of Buy and set a new price target of $13.00

    4/21/26 7:30:27 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Oracle downgraded by Cleveland Research

    Cleveland Research downgraded Oracle from Buy to Neutral

    4/10/26 8:47:06 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Leadership Updates

    Live Leadership Updates

    View All

    Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

    Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors  New Leadership and Financing, up to $354 Million ($180 Million Upfront and $174 Million Dependent on the Exercise of Milestone Warrants), Strengthen Achieve's Position to Execute Development and Launch of Cytisinicline, if Approved, as the First New Treatment for Nicotine Dependence in Two Decades SEATTLE and VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV) today announced it has appointed Andrew D. Goldberg, MD, as Chief Executive Officer and as a member of the Board of Directors, effective following the closing of Achieve's recently announced financing

    4/16/26 8:57:06 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Achieve Life Sciences Announces Up to $354 Million Private Placement

    $180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio Partners, Paradigm BioCapital Advisors and Marshall Wace SEATTLE, Wash. and VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced it has entered into a securities purchase agreement with leading healthcare investors for a private placement of its securities for

    4/16/26 8:53:49 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Oracle Appoints Hilary Maxson as Chief Financial Officer

    AUSTIN, Texas, April 6, 2026 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the appointment of Hilary Maxson as Chief Financial Officer (CFO). Maxson will report to Chief Executive Officer (CEO) Clay Magouyrk and lead the company's global finance organization, effective April 6, 2026. Maxson joins Oracle during a period of rapid growth as customer demand for cloud infrastructure exceeds supply. This growing demand for AI training and inferencing, multicloud database, and cloud applications has given Oracle the opportunity to build and scale its cloud infrastructu

    4/6/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by C4 Therapeutics Inc.

    SC 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 7:53:04 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by C4 Therapeutics Inc.

    SC 13G - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 6:43:36 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by C4 Therapeutics Inc.

    SC 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 4:05:17 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Financials

    Live finance-specific insights

    View All

    Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve) (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced financial results for the fourth quarter and full year 2025 and provided updates on the cytisinicline development program, including the announcement of its partnership with Adare Pharma Solutions (Adare). "Achieve is full

    3/24/26 7:00:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

    SEATTLE and VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced it will report its fourth quarter and full year 2025 financial results and provide a corporate update on the cytisinicline development program on Tuesday, March 24, 2026, at 8:30 AM EDT. To access the webcast, please use the following link: 4Q25 Earnings Webcast. Alternatively, you may access the live conference call by dialing 877-269-7756 (U.S. & Canada) or 201-689-7817 (International) and referenci

    3/17/26 8:30:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection

    Ignite plans to launch a new program in 2026 supporting treatment selection for more than 600,000 people in the United States living with metastatic cancer and limited therapeutic options. Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC ("Ignite"), a commercial-stage precision oncology company focused on addressing a critical challenge in cancer care: optimizing therapy selection. Ignite's functional proteomics platform has demonstrated the ability to identify cancer therapy responses that may not be captured by standard genomic testing alone. Aditxt

    3/13/26 8:15:00 AM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care